Takeda Pantozol Control

PANTOZOL Control contains the active ingredient pantoprazole, which blocks a type of pump that produces gastric acid. As a result, the amount of acid in the stomach is reduced.

PANTOZOL Control is used for the short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults. Reflux is the backflow of stomach acid into the esophagus, which can become painfully inflamed. This can cause symptoms such as a painful burning sensation in the chest that rises up to the throat (heartburn) and a sour taste in the mouth (acid reflux).

Your reflux and heartburn symptoms may be relieved after just one day of treatment with PANTOZOL Control, but this medicine may not provide immediate relief. It may be necessary to take the tablets for 2-3 consecutive days to relieve symptoms.

If you do not feel better or if you feel worse after 2 weeks, contact your doctor.

Contraindications

PANTOZOL Control must not be taken:

• if you are allergic to pantoprazole or any of the other ingredients of this medicine (listed in section 6)
• if you are also taking a medicine containing atazanavir (used to treat HIV infection). See "Other medicines and PANTOZOL Control".

interactions

Other medicines and PANTOZOL Control
Medicines containing any of the following active substances:

• Atazanavir (used to treat HIV infection). Atazanavir must not be taken concomitantly with pantoprazole. See "Do not take PANTOZOL Control".
• ketoconazole (used for fungal infections)
• Warfarin or phenprocoumon (used to thin the blood and prevent clots). Additional blood tests may be needed. -
• Methotrexate (used to treat rheumatoid arthritis, psoriasis and cancer) - if you are taking methotrexate your doctor may temporarily stop your treatment with PANTOZOL Control because pantoprazole can increase levels of methotrexate in the blood.

Do not take PANTOZOL Control with other medicines that reduce the amount of acid in the stomach, such as another proton pump inhibitor (omeprazole, lansoprazole or rabeprazole) or an H2 antagonist (e.g. ranitidine, famotidine).
However, if necessary, you may take PANTOZOL Control with antacids (eg, magaldrate, alginic acid, sodium bicarbonate, aluminum hydroxide, magnesium carbonate, or combinations thereof).

Pregnancy and breast-feeding
You should not take this medicine if you are pregnant or breast-feeding.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

application

The recommended dose is one tablet a day. Do not exceed this recommended daily dose of 20 mg pantoprazole.

Take this medicine for at least 2-3 consecutive days. Stop taking PANTOZOL Control when you are completely free of symptoms. Your symptoms of acid regurgitation and heartburn may be relieved after just one day of treatment with PANTOZOL Control, but this medicine may not provide immediate relief.

If you do not see any improvement in symptoms after 2 weeks of continuous use of this medicine, contact your doctor.
Do not take PANTOZOL Control for more than 4 weeks without consulting your doctor.

Take the tablet at the same time each day, before a meal. Swallow the tablet whole with some water. Do not chew or break the tablet.

side effects

Tell your doctor straight away or contact your nearest hospital casualty department if you experience any of the following serious side effects. Do not take any more tablets and take this leaflet and/or the tablets with you.

• Severe hypersensitivity reactions (rare: may affect up to 1 in 1000 people): Hypersensitivity reactions called anaphylactic reactions, anaphylactic shock and angioedema. Typical symptoms include: swelling of the face, lips, mouth, tongue and/or throat which may cause difficulty in swallowing or breathing, hives (hives), severe dizziness with a very fast heartbeat and profuse sweating.
• severe skin reactions (frequency not known: frequency cannot be estimated from the available data): skin rash with swelling, blistering or peeling of the skin, erosions and easy bleeding from the eyes, nose, mouth or genitals and rapid deterioration in your general condition or skin rash when exposed to the sun.
• other serious reactions (frequency not known): yellowing of the skin and eyes (due to severe liver damage) or kidney problems such as painful urination and lower back pain with fever.

Other side effects include:

• Uncommon side effects (may affect up to 1 in 100 people): headache, dizziness, diarrhea, nausea, vomiting, gas, constipation, dry mouth, pain and discomfort in the upper abdomen, skin rash or hives, itching, feeling weak, tired or generally unwell, trouble sleeping, Increase in liver enzymes in the blood test.
• Rare side effects: disturbance or complete absence of the sense of taste, visual disturbances such as blurred vision, joint pain, muscle pain, weight fluctuations, increased body temperature, swelling of the limbs, depression, increased levels of bilirubin and fat in the blood (detectable in blood tests), enlargement of the male breast, high Fever and a sharp decrease in the number of circulating granular white blood cells (seen in blood tests).
• Very rare side effects (may affect up to 1 in 10,000 users): disorientation, decrease in the number of blood platelets, which may cause you to bleed or bruise more easily, decrease in the number of white blood cells, which may lead to more frequent infections, concomitant abnormal decrease in the number of red and white blood cells as well as platelets (seen in blood tests).
• Frequency not known: hallucinations, confusion (especially in patients with a history of these symptoms), decrease in blood sodium levels, decreased blood magnesium levels; Rash, possibly with pain in the joints.

composition

What PANTOZOL Control contains

• The active substance is pantoprazole. One tablet contains 20 mg pantoprazole (as sodium 1.5 H2O).
• The other ingredients are:
  - Core: sodium carbonate, mannitol, crospovidone, povidone (K90), calcium stearate.
  - Coating: hypromellose, povidone (K25), titanium dioxide (E171), ferric hydroxide oxide x H2O (E172), propylene glycol, methacrylic acid-ethyl acrylate copolymer (1:1), sodium laurilsulfate, polysorbate 80, triethyl citrate.
  - Printing ink: shellac, ferric oxide, ferrous oxide and ferric oxide x H2O (E172), concentrated ammonia solution.